+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lysosomal Storage Disease Market 2020-2026

  • ID: 5129860
  • Report
  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Dec 31st 2021

FEATURED COMPANIES

  • Amicus Therapeutics, Inc.
  • AMO Pharma, Ltd.
  • ChiesiFarmaceuticiSpA
  • Eli Lilly Co.
  • Pfizer, Inc.
  • Sanofi S.A.
Global Lysosomal Storage Disease Market Size, Share & Trends Analysis Report by Type (Gaucher Disease, Pompe Disease, Tay-Sachs Disease, Fabry Disease, and Other (Cystinosis and Krabbe Disease)) by Treatment (Enzyme Replacement Therapy, Substrate Reduction Therapy, and Stem Cell Transplant) Forecast Period 2020-2026
The lysosomal storage disease market is projected to grow at a considerable CAGR during the forecast period (2020-2026). The factors driving the growth of the market include the increasing rate of diagnosis of the disease, awareness about the disease and research and development in the healthcare sector. The diagnosis of the disease is difficult for physicians due to the variation of symptoms for different individuals. With more research and development going on, there is an improvement in the diagnosis of the disease. There are specialized lysosomal storage disease laboratories in which specific tests can be performed to diagnose the disease. This is fueling the growth of the market.

The lysosomal storage disease market is segmented on the basis of type and treatment. Based on the type, the market is segmented into Gaucher Disease, Pompe Disease, Tay-Sachs Disease, Fabry Disease, and other (Cystinosis and Krabbe Disease). Whereas, based on the treatment, the market is segmented into enzyme replacement therapy, substrate reduction therapy, and stem cell transplant. Geographically market is segmented into North America, Europe, Asia Pacific and the Rest of the World. North America is anticipated to hold a considerable share in the lysosomal storage disease market.

Actelion Pharmaceuticals, Ltd. (A Part of Johnson & Johnson Service, Inc.), BioMarin Pharmaceuticals, Inc, Eli Lilly Co., Horizon Therapeutics, Inc., Leadiant Biosciences, Inc., Pfizer, Inc., Sanofi S.A, and Takeda Pharmaceuticals Co. Ltd. among others are the key players operating in the lysosomal Storage disease market. These companies are expanding their researches to find a treatment for the lysosomal storage disease. Moreover, these market players are actively adopting growth strategies such as mergers and acquisitions, partnerships, investment in R&D activities among others to remain competitive in the global lysosomal storage disease market.

Research Methodology

The market study of the global lysosomal storage disease market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Lysosomal Storage Disease Market Research and Analysis by Type
2. Global Lysosomal Storage Disease Market Research and Analysis by Treatment

The Report Covers
  • Comprehensive research methodology of the global lysosomal storage disease market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global lysosomal storage disease market.
  • Insights about market determinants which are stimulating the global lysosomal storage disease market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amicus Therapeutics, Inc.
  • AMO Pharma, Ltd.
  • ChiesiFarmaceuticiSpA
  • Eli Lilly Co.
  • Pfizer, Inc.
  • Sanofi S.A.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Pfizer, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Sanofi S.A.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Actelion Pharmaceuticals, Ltd.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Horizon Therapeutics, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Takeda Pharmaceuticals Co. Ltd.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities

5. Market Segmentation
5.1. Global Lysosomal Storage Disease Market by Type
5.1.1. GaucherDisease
5.1.2. Pompe Disease
5.1.3. Tay-SachsDisease
5.1.4. Fabry Disease
5.1.5. Other (Cystinosis and Krabbe Disease)
5.2. Global Lysosomal Storage Disease Market by Treatment
5.2.1. Enzyme Replacement Therapy
5.2.2. Substrate Reduction Therapy
5.2.3. Stem Cell Transplant

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Actelion Pharmaceuticals, Ltd. (A Part of Johnson & Johnson Service, Inc.)
7.2. Alexion Pharmaceuticals, Inc.
7.3. Amicus Therapeutics, Inc.
7.4. AMO Pharma, Ltd.
7.5. Arena Pharmaceuticals, Inc.
7.6. BioMarin Pharmaceuticals, Inc.
7.7. ChiesiFarmaceuticiSpA
7.8. Eli Lilly Co.
7.9. Horizon Therapeutics, Inc.
7.10. Leadiant Biosciences, Inc.
7.11. Pfizer, Inc.
7.12. ProtalixBioTherapeutics, Inc.
7.13. Sanofi S.A.
7.14. Sigilon Therapeutics, Inc.
7.15. Takeda PharmaceuticalsCo.Ltd.
Note: Product cover images may vary from those shown
  • Actelion Pharmaceuticals, Ltd. (A Part of Johnson & Johnson Service, Inc.)
  • Alexion Pharmaceuticals, Inc.
  • Amicus Therapeutics, Inc.
  • AMO Pharma, Ltd.
  • Arena Pharmaceuticals, Inc.
  • BioMarin Pharmaceuticals, Inc.
  • ChiesiFarmaceuticiSpA
  • Eli Lilly Co.
  • Horizon Therapeutics, Inc.
  • Leadiant Biosciences, Inc.
  • Pfizer, Inc.
  • ProtalixBioTherapeutics, Inc.
  • Sanofi S.A.
  • Sigilon Therapeutics, Inc.
  • Takeda Pharmaceuticals Co. Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll